Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis

Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study

(2009) Yaling Han et al.   AMERICAN HEART JOURNAL

Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials

(2009) Giuseppe De Luca et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Triple antiplatelet therapyvs.dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query

(2009) Inderjeet Singh et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

(2008) et al.   EUROPEAN HEART JOURNAL

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus

(2008) Seung-Whan Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

(2008) Yining Huang et al.   LANCET NEUROLOGY

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

(2008) Ralph L. Sacco et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility

(2008) Nikola Sprigg et al.   PLoS One

Antiplatelet drugs

(2006) Gustav Born et al.   BRITISH JOURNAL OF PHARMACOLOGY